KAIMRC-BE is a KSA Clinical Research and Bioanalytical company Headquartered at KAIMRC Medical Biotechnology Park with focus on testing generic drug and conducting clinical research.

The objectives of the bioequivalence project are:

• To establish state of art Bioequivalence facility in KAIMRC/MNG-HA.
• To improve the quality of generic drugs and health outcome for KSA and regionally.
• To establish strategic presence in the region taking advantage of the market potential.
• To build a profitable & cost effective venture.

KAIMRC-BE Business Concept Overview:

• Clinical.
• Bioanalytical.
• Other (TDM, Quality, Abused drugs…..).

Bioanalytical Unit Operation:

• Generic Drugs.
• Therapeutic Drug Monitoring (TDM).
• Quality Control Test for the Pharmaceutical drugs delivered to the MNG-HA and Other Health Organizations and private sector.